MediXall Group, Inc. (MDXL)
OTCMKTS · Delayed Price · Currency is USD
0.0056
0.00 (0.00%)
At close: Jun 1, 2026

MediXall Group Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingSep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Revenue
0.30.310.060.01-0
Revenue Growth
29.41%422.07%295.25%--44.51%
Gross Profit
-0.66-0.93-3.14-3.05-2.53-1.37
Operating Income
-1.97-3.92-6.32-6.37-5.93-3.42
Net Income
-2.43-4.88-7.14-6.45-5.97-3.42
Earnings Per Share
-0.02-0.04-0.06-0.06-0.07-0.05
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingSep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash & Investments
0.030.0100.060.650.45
Total Debt
0.613.832.820.320.210.12
Net Cash (Debt)
-0.58-3.82-2.82-0.250.430.33
Net Cash Growth
----31.73%63.06%
Net Cash Per Share
-0.00-0.03-0.02-0.000.000.00

Cash Flow & CapEx

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingSep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Operating Cash Flow
-1.2-1.23-3.56-4.69-4.13-2.34
Capital Expenditures
---0-0-0.01-0.01
Free Cash Flow
-1.2-1.23-3.56-4.69-4.14-2.35
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingSep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Operating Margin
-645.91%-1265.64%-10665.08%-42456.11%--127409.72%
Pretax Margin
-710.77%-1474.82%-11524.63%-41350.94%--127409.72%
Profit Margin
-798.78%-1576.10%-12053.42%-43014.33%--127409.72%
FCF Margin
-395.05%-397.37%-6010.77%-31251.15%--87617.95%

Valuation

Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJul '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
PS Ratio
3.8601309.127582.56-56393.83